Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.

BACKGROUND: To our knowledge, the use of psychotropic medications (antidepressant, anxiolytic, and hypnotic agents) in patients with asthma has not been extensively explored. OBJECTIVE: To identify factors associated with the use of these medications in patients with asthma. METHODS: Regular custom...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Laforest, L, Van Ganse, E, Devouassoux, G, Osman, L, Pison, C, El Hasnaoui, A, Bauguil, G, Chamba, G
Format: Journal article
Sprache:English
Veröffentlicht: 2008
_version_ 1826280475288666112
author Laforest, L
Van Ganse, E
Devouassoux, G
Osman, L
Pison, C
El Hasnaoui, A
Bauguil, G
Chamba, G
author_facet Laforest, L
Van Ganse, E
Devouassoux, G
Osman, L
Pison, C
El Hasnaoui, A
Bauguil, G
Chamba, G
author_sort Laforest, L
collection OXFORD
description BACKGROUND: To our knowledge, the use of psychotropic medications (antidepressant, anxiolytic, and hypnotic agents) in patients with asthma has not been extensively explored. OBJECTIVE: To identify factors associated with the use of these medications in patients with asthma. METHODS: Regular customers (aged 18-50 years) of 348 pharmacies in 9 French regions were consecutively recruited from November 2003 to June 2004. Patients with a prescription for an asthma medication were included. Patients completed a questionnaire, complemented by the computerized records of their therapy dispensed in the past 12 months. Asthma control was measured with the Asthma Control Test. RESULTS: Among 886 patients (mean age, 37.4 years; 55.0% female), during the 12 months before the survey, the proportions who received at least 1 U of anxiolytic, antidepressant, and hypnotic agents were 25.6%, 13.7%, and 13.0%, respectively. Higher dispensing levels of antidepressant, anxiolytic, and hypnotic agents were observed with decreasing asthma control (P < .001 for each drug class). Other correlates of receiving any of these classes included older age, female sex, smoking status, and dispensing of antireflux treatment (P < .001 for all). These results were confirmed in multivariate analyses. CONCLUSIONS: Psychotropic drugs were commonly dispensed to patients with asthma, and correlates of receiving these drugs were identified in this population. The high use of psychotropic medication, particularly in patients with poorly controlled asthma, is of concern.
first_indexed 2024-03-07T00:14:16Z
format Journal article
id oxford-uuid:7a4775c6-43c5-45ea-80be-a0c2f67a1014
institution University of Oxford
language English
last_indexed 2024-03-07T00:14:16Z
publishDate 2008
record_format dspace
spelling oxford-uuid:7a4775c6-43c5-45ea-80be-a0c2f67a10142022-03-26T20:43:03ZFactors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7a4775c6-43c5-45ea-80be-a0c2f67a1014EnglishSymplectic Elements at Oxford2008Laforest, LVan Ganse, EDevouassoux, GOsman, LPison, CEl Hasnaoui, ABauguil, GChamba, G BACKGROUND: To our knowledge, the use of psychotropic medications (antidepressant, anxiolytic, and hypnotic agents) in patients with asthma has not been extensively explored. OBJECTIVE: To identify factors associated with the use of these medications in patients with asthma. METHODS: Regular customers (aged 18-50 years) of 348 pharmacies in 9 French regions were consecutively recruited from November 2003 to June 2004. Patients with a prescription for an asthma medication were included. Patients completed a questionnaire, complemented by the computerized records of their therapy dispensed in the past 12 months. Asthma control was measured with the Asthma Control Test. RESULTS: Among 886 patients (mean age, 37.4 years; 55.0% female), during the 12 months before the survey, the proportions who received at least 1 U of anxiolytic, antidepressant, and hypnotic agents were 25.6%, 13.7%, and 13.0%, respectively. Higher dispensing levels of antidepressant, anxiolytic, and hypnotic agents were observed with decreasing asthma control (P < .001 for each drug class). Other correlates of receiving any of these classes included older age, female sex, smoking status, and dispensing of antireflux treatment (P < .001 for all). These results were confirmed in multivariate analyses. CONCLUSIONS: Psychotropic drugs were commonly dispensed to patients with asthma, and correlates of receiving these drugs were identified in this population. The high use of psychotropic medication, particularly in patients with poorly controlled asthma, is of concern.
spellingShingle Laforest, L
Van Ganse, E
Devouassoux, G
Osman, L
Pison, C
El Hasnaoui, A
Bauguil, G
Chamba, G
Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.
title Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.
title_full Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.
title_fullStr Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.
title_full_unstemmed Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.
title_short Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey.
title_sort factors influencing dispensing of psychotropic medications to patients with asthma a community pharmacy based survey
work_keys_str_mv AT laforestl factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey
AT vangansee factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey
AT devouassouxg factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey
AT osmanl factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey
AT pisonc factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey
AT elhasnaouia factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey
AT bauguilg factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey
AT chambag factorsinfluencingdispensingofpsychotropicmedicationstopatientswithasthmaacommunitypharmacybasedsurvey